Please login to the form below

Not currently logged in
Email:
Password:

Ashley Communications celebrates 20 years of medical communications

Looks forward with new business wins, including AbbVie and Merck & Co accounts

Ashley CommunicationsBuckinghamshire, UK-based Ashley Communications marked two decades of medical communications consulting at the close of 2016, a year that saw the firm strengthen its position with several new business wins.

The consultancy is set to put its expertise in strategic counsel, digital and patient engagement, clinical trial communications and opinion leader development to use for eight new clients this year.

Among this number are big pharma firms Abbvie, Allergan and Merck & Co, as well as UK-based Abbott Diagnostics, opioid addiction specialist Indivior, Tokyo-based Otsuka, detection and informatics specialist Perkin Elmer and Torax Medical, a gastroenterology-focused firm.

Ashley Communications chairman Chrissie Ashley, said: “Our key objective for 2016 was to broaden our client base and to fully utilise the therapeutic experience we have within our agency.

“We are delighted with the results, which put us in a strong position starting 2017.

“We also believe our partnership with Southwood research, which was announced earlier this year, has contributed to our success by providing a truly combined service that really adds value to the services we offer our clients.”

Article by
Rebecca Clifford

11th January 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics